1.Botox® is a prescription medicine for the treatment of frown lines, horizontal forehead lines and crow’s feet around the eyes
Botox® has risks and benefits.
Ask your doctor if Botox is right for you. If you have side effects, see your doctor. You will need to pay for Botox® and clinic fees will apply.
For details on precautions & side effects consult your healthcare professional or the Consumer Medicine Information (CMI) at www.medsafe.govt.nz .
Botox® treatment lasts about 4 months and further courses of treatment may be necessary.
Should only be administered by trained medical professionals. (contains botulinum toxin A 50,100 & 200 units)
Allergan (NZ) Limited, Auckland.
2. Juvederm Ultra™ & Juvederm Ultra Plus™ are medical devices Class III for the filling of medium-sized and deep facial wrinkles by injection into the skin and for creating definition and volume in the lips. Contains 24mg/mL. cross-linked hyaluronic acid
Juvederm has risks and benefits.
Cautions: Use in an area that has been treated with another dermal filler, people with autoimmune disease, or who are pregnant, breastfeeding, under 18 years of age or have an increased susceptibility to keloid formation and hypertrophic scarring. People on blood thinning medicines.
Possible side effects: injection site inflammatory reactions (redness/swelling, itching/pain on pressure) induration or nodules; discolouration; weak filling effect. If you have side effects or concerns speak to your doctor.
Product and treatment costs will apply.
Note: Juvederm treatment lasts about 12-24 months.
For product information check with your doctor or product information at Allergan (NZ) Limited, Auckland.
3. Restylane® is a gel containing hyaluronic acid and lidocaine that is injected by a healthcare professional into or below the skin to smooth facial wrinkles and enhance lips by restoring volume and fullness. Restylane is a Class III medical device and has risks and benefits.
Restylane® treatment may result in some redness, swelling, pain or tenderness, itching and/or bruising which may last a few days. Inflammatory reactions can begin up to two to four weeks after treatment in rare cases. See your healthcare professional if any side effects concern you. Exposure to excessive sunlight or extreme cold should be avoided until redness or swelling has resolved.
Restylane® should not be used in an area where there is a non-resorbable implant or in irritated or infected skin, Restylane® should not be used in people taking blood thinning medicines or who have an allergy to hyaluronic acid, lidocaine or other local anaesthetics. Caution if you take medicines that prolong bleeding time.
Treatment lasts 12-24 months.
Restylane has not been tested in pregnant or breast-feeding women. ALWAYS FOLLOW THE INSTRUCTIONS YOU ARE GIVEN. Galderma, Auckland. Distributed by Healthcare Logistics, Auckland
4. Restylane® Skinboosters is a gel containing hyaluronic acid that is injected into or below the skin to improve skin structure, hydration and elasticity.
Restylane® Skinboosters is a medical device class III that has risks and benefits.
Do not use in patients with bleeding disorders, or in patients taking blood-thinning medicines. Do not inject intravascularly, where there
is active disease, inflammation, infection, or tumours near the intended treatment site
Possible side effects are injection site effects like swelling, bruising, tenderness and inflammation.
Treatment usually lasts 6-12 months.
Product and treatment costs will apply.
Consult your cosmetic practitioner for further information.
Further product details can also be found in the full product information.
Galderma, Auckland.
5. Dysport® is a prescription medicine for the treatment of frown lines, horizontal forehead lines and crow’s feet around the eyes.
Dysport has risks and benefits.
Ask your doctor if Dysport is right for you. If you have side effects see your doctor. You will need to pay for Dysport, and clinic fees will apply.
For details on precautions & side effects consult your healthcare professional or the Consumer Medicine Information (CMI) at www.medsafe.govt.nz
Dysport lasts about 4-6 months and further courses of treatment may be necessary.
Should only be administered by trained medical professionals. Contains 500 units of clostridium botulinum Type A toxin. Galderma (NZ) Limited, Auckland.
6. Belotero® is a Class III medical device to smooth facial wrinkles and folds, correct facial atrophic scars, restore or enhance the lips or restore facial volume
Belotero has risks and benefits. Ask your specialist if Belotero is right for you.
Contains transparent cross-linked sodium hyaluronate gel of non-animal origin with lidocaine 0.3% to reduce local pain.
Do not use if you have a skin inflammation or a skin infection or until the infection is healed.
Precautions. There is a risk of infection. Tell your doctor if you are on blood-clotting medicines as there could be an increased risk of bruising or bleeding at the injection site.
Possible side effects: swelling, bruising, redness hardening of the skin, pain, altered colour or itching.
Lasts 6-12 months
You will need to pay for this product and doctor’s fees apply. Merz, Sydney. Distributed by Healthcare Logistics, Auckland
7. Xeomin® is a Prescription Medicine containing 50, 100 units of incobotulinum Type A, purified Botulinum toxin type A complex for injection. It is used for the treatment of frown lines on the forehead, lateral periorbital lines and horizontal forehead lines in adults. It should be administered only by trained medical professionals. Talk to your specialist about the benefits/risks of this procedure in appearance medicine. Xeomin treatment lasts about four months and further courses of treatment may be necessary. Cautions: people receiving blood-thinning medicines, care at the proposed injection sites, pregnancy and lactation. Possible side effects: headache, pain, swelling or infection at the injection site, local muscle weakness including drooping eyelids, lack of feeling & nausea.
Treatment lasts for up to 4 months.
You will need to pay for this medicine. Discuss with your specialist if Xeomin is right for you. For more information or for a copy of CMI please contact the NZ distributor: Merz, Sydney. Distributed by Healthcare Logistics, Auckland
9.Sculptra® is a poly-L-lactic acid implant liquid that is injected by a healthcare professional into or below the skin to increase volume of depressed areas, particularly to correct skin depressions.
Class III Medical Device. Sculptra® may also be used for large-volume restoration and/or correction of the signs of facial fat loss.
Sculptra has risks and benefits.
Sculptra® treatment may result in injection site reactions and pain. Ask your healthcare professional to explain the range of possible side effects and tell them if any side effects concern you.
Sculptra® should not be injected into the skin that is inflamed or infected. Exposure to excessive sunlight or UV lamp exposure should be avoided until redness or swelling has resolved. Sculptra® is not recommended for people taking blood-thinning medicines and has not been tested in pregnant or breast-feeding women or those aged under 18 years.
Lasts for 12-25 months
ALWAYS FOLLOW THE INSTRUCTIONS YOU ARE
GIVEN. Galderma Australia, Sydney. Distributed by Healthcare Logistics Auckland.
9. Profhilo®, containing low & high molecular weight hyaluronic acid, is a Class III medical device for the treatment of the face and body for contours redefinition and laxity remodelling where skin laxity is a problem.
Profhilo has risks and benefits.
Do not use with treatments such as laser resurfacing or medium deep skin-peeling.
Caution in people on blood thinning medicines.
Do not inject into inflamed areas or intravenously or intramuscularly.
Possible side effects: pain and swelling at the injection site. Accelagen Pty. Ltd. Whanganui.
10. BELKYRA® injection is a prescription medicine containing 10 mg/mL deoxycholic acid. It is used for the improvement in the appearance of moderate to severe convexity or fullness associated with fat below the jaws in adults.
Do not use in people allergic to this medicine, with infection at the site of injection, pregnancy, and lactation.
Possible side effects include headaches, difficulty swallowing, nausea, skin tightness, hypertension, injection site bruising/pain/swelling/numbness/redness/tingling/hardness/itching /discolouration/formation of small areas of hardness/warmth and injection site nerve injury.
BELKYRA® treatment is not funded on the New Zealand Pharmaceutical Schedule. You will need to pay for this medicine. Normal Doctor’s visit fees apply. BELKYRA® treatment should be administered only by trained medical professionals. Speak to your specialist about your own situation and about the benefits/risks of this procedure in appearance medicine. For further information, the Data Sheet and Consumer Medicines Information can be accessed at www.medsafe.govt.nz or ask your doctor. If you have any side effects or concerns speak to your doctor. Note: Results from BELKYRA® treatment usually last up to 4 years.
Allergan New Zealand Limited, Auckland.
11. TEOSYAL RHA® 1, TEOSYAL RHA® 2, TEOSYAL RHA® 3, TEOSYAL RHA® 4, TEOSYAL® PURESENSE REDENSITY 1, TEOSYAL® PURESENSE REDENSITY 2, TEOSYAL PURESENSE KISS ®, TEOSYAL® PURESENSE GLOBAL ACTION, TEOSYAL® PURESENSE DEEP LINES, TEOSYAL® PURESENSE ULTIMATE and TEOSYAL® PURESENSE ULTRA DEEP TEOSYAL KISS®, RHA KISS®, TEOSYAL® MESO, TEOSYAL® GLOBAL ACTION, TEOSYAL® DEEP LINES, , TEOSYAL® ULTIMATE and TEOSYAL® ULTRA DEEP are trademark of the firm TEOXANE SA. These products are a gel that contains hyaluronic acid, and 0.3% by weight of lidocaine hydrochloride They are class III medical devices.
Caution for people on blood thinning medicines.
Local side effects: inflammatory reactions (redness, oedema, pain at the point of injection), haematomas, itching, temporary loss of sensitivity around the injected area, disorders of pigmentation in
skin and hair, abscesses, indurations, nodules (possibly granulomas).
General manifestations: immediate hypersensitivity up to anaphylactic shock, migration of the implant.
Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment or blindness, skin necrosis and stroke.
Lasts 9 -12 months.
Please consult your doctor or pharmacist for more information. Please refer to instructions for use, local distributor. Healthcare Logistics, Auckland.
